INDUSTRY INSIGHTS YOUR PEERS ARE READING
At long last, we seem to be on the threshold of departing the earliest phases of AI, defined by the always tedious “will AI replace doctors/drug developers/occupation X?” By DAVID SHAYWITZ MD. MORE
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States. MORE
136 
DiMasi, PhD, who analyzes the economics of health care at the Tufts University Center for the Study of Drug Development. We’ve seen very large trials and lengthening clinical development times, which would suggest larger than average development costs,” DiMasi said. MORE
For physicians, this would enable customized individual treatment plans co-developed by a patient’s various caregivers, based on full histories, patient genetics, lifecycle and environment. Interoperability. Blockchain. MORE
But key facets of its business didn’t develop as planned, say people familiar with the company. It had hoped to sell analytics to pharmaceutical companies as they increasingly incorporated genetic sequencing into drug development, these people say. Human Longevity Inc. MORE
Blockchain was first developed as a means of transaction for the digital currency Bitcoin. Blockchain technology’s potential impact on the life sciences industry (drug development, distribution and prescribing) is significant. It can impact the opioid crisis and improve tracking drugs in the supply chain. One can envision how blockchain might also stop drug counterfeiting thereby improving patient safety. MORE
A drug prescription can come with a lot of questions. With our “Know Your Drugs” series, we provide you with a snapshot of the different diabetes drugs on the market, and links to additional information. MORE
However, the agency states that the new test by 23andMe can’t assess whether a drug is appropriate or be considered by users to be medical advice. RESEARCH & DRUG DEVELOPMENt. The Fourth Wave: Digital Health Newsletter — Nov 6, 2018 — No. MORE
The study’s authors urge policymakers to support the development of new strategies to prevent infections and to support innovative antibiotic drug development A new study finds that antibiotic resistance adds more than $1,000 to the cost of treatment for a single patient. Multiply that by the estimated number of antibiotic-resistant infections, and costs run well over $2 billion per year. MORE
“The Global Clinical Trials Connect 2018 conference focuses on introducing pioneer technology, developing better patient engagement and collaborating strategies in clinical trials. Aji Barot, Business Development Director, HealthUnlocked. MORE
has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. The acquisition is an attempt by Lilly to bolster its troubled drug pipeline. MORE
This legislation boosts funding to the National Institutes of Health and establishes an innovation grant fund to “accelerate the discovery, development, and delivery” of new treatments and therapies. She also said the bill opened the door to easy off-label use of FDA-cleared drugs. “I MORE
The company uses AI to speed up the drug development process and has a particular focus on therapies for Parkinsons and ALS, which it plans to test in humans several years from now. I made this announcement to 63,919 members of the Digital Health group on LinkedIn. MORE
has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. The acquisition is an attempt by Lilly to bolster its troubled drug pipeline. MORE
” During F8, Facebook’s annual developer conference, CEO Mark Zuckerberg announced the launch of a new dating service. I made this announcement to 62,782 members of the Digital Health group on LinkedIn. MORE
While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.” ” As I point out in my book, drug development could involve a model of direct government funding and licensing. MORE
It’s hoped that by identifying symptoms as they are developing and before they manifest completely treatment can begin earlier. In the UK, six drug companies will decode the genes of 500,000 Brits and make the data public by 2020 via the UK Biobank. MORE
CVC’s recent acquisition of the women’s health division of the Israeli drug developer Teva for $800m created a company dedicated to contraception, fertility, menopause and osteoporosis. Silicon Valley Bank, Zinc.vc MORE
Of the 50,000 drug overdose deaths that occurred in 2015, roughly 33,000 of them were caused by opioids. More forms of technology are being developed every day to treat patients suffering from chronic pain, and to remedy those that may be struggling with an opioid addiction. MORE
Auckland University of Technology researchers have developed a first-of-its-kind artificial intelligence “spiking neural networks” machine learning system that obtains brain data from EEG headsets and can then predict a person’s choices 0.2 MORE
In his studies, Type 1 diabetic patients have significantly benefited when their daily insulin regimen is supplemented with drugs developed to treat Type 2 diabetes. This was the first research ( release ) on using this Type 2 approved drug for T1D treatment and there were larger confirmatory studies ( release ) in 2016 and 2018. The study will supplement insulin therapy with these two drugs designed to treat Type 2 Diabetes or with semaglutide alone. “ MORE
Within a bullet point about Obamacare is this sentence: “Reforms will also include cutting the red tape at the FDA: there are over 4,000 drugs awaiting approval, and we especially want to speed the approval of life-saving medications.”. MORE
In an interview with the Wall Street Journal, Narasimhan pointed to some of the investments the company has made into the cutting-edge areas of drug development, such as gene therapy and radiopharmaceuticals. MORE
” Coinicidentally, while attending an event at the Salk Institute here in San Diego today, someone said pretty much the same thing to me regarding traditional versus digital-enabled modern drug development: “we can’t go back.” MORE
From drug developers all the way to providers, it’s key to find secure ways to access and use data to improve human health, all while protecting individuals’ privacy. From drug developers all the. The Fourth Wave: Digital Health Newsletter — Nov 13, 2018 — No. MORE
has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. The acquisition is an attempt by Lilly to bolster its troubled drug pipeline. MORE
Most people don't know it but there is a multi-billion dollar industry that collects healthcare information, strips it of basic personal identifiers such as name, address and Social Security Number, and then sells it off to researchers, drug developers, marketers and others. MORE
Drug Development Related Topics Healthcare Guys
NOVEMBER 16, 2018
At long last, we seem to be on the threshold of departing the earliest phases of AI, defined by the always tedious “will AI replace doctors/drug developers/occupation X?” By DAVID SHAYWITZ MD.
Mobi Health News
APRIL 20, 2018
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States.
Duane Boise
JANUARY 24, 2018
Of the 50,000 drug overdose deaths that occurred in 2015, roughly 33,000 of them were caused by opioids. More forms of technology are being developed every day to treat patients suffering from chronic pain, and to remedy those that may be struggling with an opioid addiction.
FierceHealthIT
MARCH 22, 2018
The study’s authors urge policymakers to support the development of new strategies to prevent infections and to support innovative antibiotic drug development A new study finds that antibiotic resistance adds more than $1,000 to the cost of treatment for a single patient. Multiply that by the estimated number of antibiotic-resistant infections, and costs run well over $2 billion per year.
Story of Digital Health
NOVEMBER 14, 2018
From drug developers all the way to providers, it’s key to find secure ways to access and use data to improve human health, all while protecting individuals’ privacy. From drug developers all the. The Fourth Wave: Digital Health Newsletter — Nov 13, 2018 — No.
Story of Digital Health
NOVEMBER 9, 2018
However, the agency states that the new test by 23andMe can’t assess whether a drug is appropriate or be considered by users to be medical advice. RESEARCH & DRUG DEVELOPMENt. The Fourth Wave: Digital Health Newsletter — Nov 6, 2018 — No.
|
Insulin Nation
NOVEMBER 27, 2018
In his studies, Type 1 diabetic patients have significantly benefited when their daily insulin regimen is supplemented with drugs developed to treat Type 2 diabetes. This was the first research ( release ) on using this Type 2 approved drug for T1D treatment and there were larger confirmatory studies ( release ) in 2016 and 2018. The study will supplement insulin therapy with these two drugs designed to treat Type 2 Diabetes or with semaglutide alone. “
Lloyd Price
NOVEMBER 21, 2018
In an interview with the Wall Street Journal, Narasimhan pointed to some of the investments the company has made into the cutting-edge areas of drug development, such as gene therapy and radiopharmaceuticals.
HitPoint Blog
JUNE 28, 2018
For physicians, this would enable customized individual treatment plans co-developed by a patient’s various caregivers, based on full histories, patient genetics, lifecycle and environment. Interoperability. Blockchain.
Lloyd Price
DECEMBER 8, 2018
But key facets of its business didn’t develop as planned, say people familiar with the company. It had hoped to sell analytics to pharmaceutical companies as they increasingly incorporated genetic sequencing into drug development, these people say. Human Longevity Inc.
Insulin Nation
OCTOBER 16, 2015
has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. The acquisition is an attempt by Lilly to bolster its troubled drug pipeline.
|
|
Story of Digital Health
JULY 20, 2018
The company uses AI to speed up the drug development process and has a particular focus on therapies for Parkinsons and ALS, which it plans to test in humans several years from now. I made this announcement to 63,919 members of the Digital Health group on LinkedIn.
Lloyd Price
JUNE 4, 2018
CVC’s recent acquisition of the women’s health division of the Israeli drug developer Teva for $800m created a company dedicated to contraception, fertility, menopause and osteoporosis. Silicon Valley Bank, Zinc.vc
Insulin Nation
NOVEMBER 14, 2016
Within a bullet point about Obamacare is this sentence: “Reforms will also include cutting the red tape at the FDA: there are over 4,000 drugs awaiting approval, and we especially want to speed the approval of life-saving medications.”.
Insulin Nation
DECEMBER 14, 2016
This legislation boosts funding to the National Institutes of Health and establishes an innovation grant fund to “accelerate the discovery, development, and delivery” of new treatments and therapies. She also said the bill opened the door to easy off-label use of FDA-cleared drugs. “I
Insulin Nation
OCTOBER 16, 2015
has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. The acquisition is an attempt by Lilly to bolster its troubled drug pipeline.
Story of Digital Health
SEPTEMBER 11, 2018
Auckland University of Technology researchers have developed a first-of-its-kind artificial intelligence “spiking neural networks” machine learning system that obtains brain data from EEG headsets and can then predict a person’s choices 0.2
Insulin Nation
OCTOBER 10, 2017
A drug prescription can come with a lot of questions. With our “Know Your Drugs” series, we provide you with a snapshot of the different diabetes drugs on the market, and links to additional information.
mHealth Insight
APRIL 24, 2018
“The Global Clinical Trials Connect 2018 conference focuses on introducing pioneer technology, developing better patient engagement and collaborating strategies in clinical trials. Aji Barot, Business Development Director, HealthUnlocked.
Story of Digital Health
APRIL 24, 2018
While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.” ” As I point out in my book, drug development could involve a model of direct government funding and licensing.
Lloyd Price
SEPTEMBER 9, 2018
Most people don't know it but there is a multi-billion dollar industry that collects healthcare information, strips it of basic personal identifiers such as name, address and Social Security Number, and then sells it off to researchers, drug developers, marketers and others.
Insulin Nation
OCTOBER 16, 2015
has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. The acquisition is an attempt by Lilly to bolster its troubled drug pipeline.
Story of Digital Health
JANUARY 15, 2018
It’s hoped that by identifying symptoms as they are developing and before they manifest completely treatment can begin earlier. In the UK, six drug companies will decode the genes of 500,000 Brits and make the data public by 2020 via the UK Biobank.
Story of Digital Health
MAY 9, 2018
” During F8, Facebook’s annual developer conference, CEO Mark Zuckerberg announced the launch of a new dating service. I made this announcement to 62,782 members of the Digital Health group on LinkedIn.
Story of Digital Health
APRIL 10, 2018
” Coinicidentally, while attending an event at the Salk Institute here in San Diego today, someone said pretty much the same thing to me regarding traditional versus digital-enabled modern drug development: “we can’t go back.”
Insulin Nation
JULY 14, 2015
DiMasi, PhD, who analyzes the economics of health care at the Tufts University Center for the Study of Drug Development. We’ve seen very large trials and lengthening clinical development times, which would suggest larger than average development costs,” DiMasi said.
Let's personalize your content